Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Volpe

Showing results (181-190 of 820) with videos related to

Pageof 82
Sort By:
European Heart Journal|December 14, 2024
Weekly Journal Scan: HELIOS-B sheds light on new therapeutic options for transthyretin amyloidosis with cardiomyopathyDaniela Pedicino, Massimo Volpe
European Heart Journal|February 21, 2022
Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debateGiovanna Liuzzo, Massimo Volpe
European Heart Journal|February 15, 2022
PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fractionGiovanna Liuzzo, Massimo Volpe
European Heart Journal|January 26, 2022
VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan?Massimo Volpe, Giovanna Liuzzo
European Heart Journal|April 9, 2023
Bempedoic acid: a CLEAR therapeutic option for statin-intolerant patients?Massimo Volpe, Carlo Patrono
European Heart Journal|April 21, 2021
Cryoblation as first-line treatment of new-onset atrial fibrillation?Leonarda Galiuto, Massimo Volpe
European Heart Journal|May 19, 2023
Coffee drinking and cardiac ectopic beats: Black or White?Daniela Pedicino, Massimo Volpe
European Heart Journal|January 19, 2024
A new RNA-interference based strategy is associated with mild beneficial effects in patients with heart failure due to cardiac amyloidosisLeonarda Galiuto, Massimo Volpe
Hypertension (Dallas, Tex. : 1979)|May 21, 2014
Impact of the direct angiotensin II type 2 receptor stimulation on renal function toward a sex-specific therapeutic approach for hypertensionCarmine Savoia, Massimo Volpe
European Heart Journal|November 28, 2023
Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?Rocco Vergallo, Massimo Volpe
Pageof 82

Showing results (181-190 of 820) with videos related to

Sort By:
Pageof 82
European Heart Journal|December 14, 2024
Weekly Journal Scan: HELIOS-B sheds light on new therapeutic options for transthyretin amyloidosis with cardiomyopathyDaniela Pedicino, Massimo Volpe
European Heart Journal|February 21, 2022
Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debateGiovanna Liuzzo, Massimo Volpe
European Heart Journal|February 15, 2022
PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fractionGiovanna Liuzzo, Massimo Volpe
European Heart Journal|January 26, 2022
VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan?Massimo Volpe, Giovanna Liuzzo
European Heart Journal|April 9, 2023
Bempedoic acid: a CLEAR therapeutic option for statin-intolerant patients?Massimo Volpe, Carlo Patrono
European Heart Journal|April 21, 2021
Cryoblation as first-line treatment of new-onset atrial fibrillation?Leonarda Galiuto, Massimo Volpe
European Heart Journal|May 19, 2023
Coffee drinking and cardiac ectopic beats: Black or White?Daniela Pedicino, Massimo Volpe
European Heart Journal|January 19, 2024
A new RNA-interference based strategy is associated with mild beneficial effects in patients with heart failure due to cardiac amyloidosisLeonarda Galiuto, Massimo Volpe
Hypertension (Dallas, Tex. : 1979)|May 21, 2014
Impact of the direct angiotensin II type 2 receptor stimulation on renal function toward a sex-specific therapeutic approach for hypertensionCarmine Savoia, Massimo Volpe
European Heart Journal|November 28, 2023
Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?Rocco Vergallo, Massimo Volpe
Pageof 82